Journal of Innovation in Cardiac Rhythm Management
banner atricure hvs2022

 

Introduction

This 1-hour enduring CME accredited on-demand webcast features the proceedings of an official satellite symposium that occurred during the Heart Valve Society 2022 Scientific Meeting.

Agenda

tmb AtriCure hvs2022 panel  

Viewing Options:
Click on the presentation titles below to view individual segments of the activity, or the Access Button to view the activity in its entirety.

CME/CE Credit:
To earn credit, participants must access the Obtain Credit tab, and successfully complete the post-activity CME test.

Agenda
LAAOS III – The Significance to the Practice of Surgical LAA Exclusion
Richard Whitlock, MD, PhD
CHA2DS2-VASc Score and Anticoagulation Following the Cox Maze Procedure. Is there a Need for a Different Scoring System?
Niv Ad, MD
Standalone Epicardial LAA Exclusion for Thromboembolism Prevention in Atrial Fibrillation
Richard Cartledge, MD
Prophylactic Epicardial LAA Exclusion for Thromboembolism Prevention in High-Risk Patients
Basel Ramlawi, MD
Panel Discussion with Q&A Session
Moderator: Niv Ad, MD
Panelists: Richard Cartledge, MD, Basel Ramlawi, MD, Richard Whitlock, MD, PhD

Educational grant support provided by:
AtriCure

Joint Providership
MediaSphere Medical, LLC and Ciné-Med

 

Faculty

Faculty

Niv Ad MD

Niv Ad, MD
White Oaks Medical Center
University of Maryland
Silver Spring, MD

 

   Basel Ramlawi MD

Basel Ramlawi, MD
Lankenau Heart Institute
Mainline Health System
Philadelphia, PA
Richard Cartledge MD

Richard Cartledge, MD
Boca Raton Regional Hospital
Boca Raton, FL

   Richard Whitlock MD

Richard Whitlock, MD, PhD
McMaster University Medical School
Hamilton, Canda

CME Accreditation

CME Released: 12/1/2023; Valid for credit through 12/1/2024

CME Certificate Fulfillment
To successfully earn credit, participants must complete the activity online during the valid credit period that is noted above. To receive CME Credits, you must receive a minimum score of 75% on the post-test, accessible at Obtain Credit page. CME/CE certificates are issued to your inbox upon successful completion.

Target Audience
This enduring activity is intended to meet the educational needs of the multidisciplinary team of physicians and allied healthcare professionals who are dedicated to the management of heart valve disease.

Learning Objectives
Upon completion of this educational activity, participants will be able to:

  • Review the results of LAAOS III, and assess impact to the practice of surgical LAA exclusion.
  • Examine CHA2DS2-VASc Score and Anticoagulation following the Cox Maze Procedure, and alternative scoring system options.
  • Assess the rationale and benefits of standalone epicardial LAA exclusion for thromboembolism prevention in Atrial Fibrillation.
  • Review the rationale and benefits of prophylactic epicardial LAA exclusion for thromboembolism prevention in high-risk patients.

Activity Goal
This activity is designed to address the following core and team competencies:
Patient care, medical knowledge, practice-based learning and improvement, interprofessional collaboration, and roles and responsibilities.

Accreditation Statement
Jointly Accredited Provider TMTo support the improvement of patient care, this activity has been planned and implemented by MediaSphere Medical and Ciné-Med. Ciné-Med is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health-care team.

Ciné-Med designates this educational activity for a maximum of 1 AMA PRA CATEGORY 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.

Ciné-Med designates this activity for 1 Contact Hours for nurses.

Disclosure Policy
MediaSphere Medical and Ciné-Med adheres to accreditation requirements concerning industry support of continuing medical education. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations. Speakers will disclose any relationships at the beginning of their presentations.
All MediaSphere Medical and Ciné-Med employees in control of content have indicated that they have no relevant financial relationships to disclose.

It is the policy of MediaSphere Medical and Ciné-Med to ensure balance, independent objectivity, and scientific rigor in all its supported educational programs. All faculty members participating in educational activities are required to disclose to the program audience any real of apparent conflicts of interest held within the past 12 months.

MediaSphere Medical and Ciné-Med implement a mechanism to identify and resolve all conflicts of interest prior to delivering the educational activity to learners.

Non-Endorsement Statement
MediaSphere Medical and Ciné-Med verify that sound education principles have been demonstrated in the development of this educational offering as evidenced by the review of its objectives, teaching plan, faculty, and activity evaluation process. MediaSphere Medical and Ciné-Med does not endorse or support the actual opinions or material content as presented by the speaker(s) and/or sponsoring organization.

Educational grant support provided by:
AtriCure

Joint Providership
MediaSphere Medical, LLC and Ciné-Med

 

Obtain Credit

 
CME/CE Test
  1. Surgical LAA Exclusion: State-of-the-Art
  2. Please complete the following CME/CE post-test. Your submission will be reviewed and notification provided shortly regarding certificate fulfillment status. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

  3. First Name: *  
    Invalid Input
  4. Last Name: *  
    Invalid Input
  5. Primary Email Address: *  
    Invalid Input
  6. Confirm Your Email: *  
    Invalid Input
  7. Degree: *  
    Invalid Input
  8. Specialty:*  
    Invalid Input
  9. Institution: *  
    Invalid Input
  10. Mailing Address:*  
    Invalid Input
  11. City: *  
    Invalid Input
  12. State: *  
    Invalid Input

  13. 1) When evaluating the evidence from the Left Atrial Appendage Occlusion Study (LAAOS III), which conclusion is accurate?
  14. Select one*  





    Invalid Input Please Select one

  15. 2) Standalone LAAE using Atriclip is safe, effective, and definitive, and should be considered as a viable therapeutic option in non-valvular Afib patients at high risk for bleeding?
  16. Select one*  


    Invalid Input Please Select one

  17. 3) The presence of incomplete surgical LAA closure is associated with a significantly increased risk of thromboembolism in AF patients after mitral valve surgery?
  18. Select one*  


    Invalid Input Please Select one

  19. 4) When assessing the role of Prophylactic Epicardial LAA Exclusion for Thromboembolism Prevention in High-Risk Patients, LAA Exclusion in cardiac surgery patients with Afib is a must; while LAA Exclusion in cardiac surgery patients WITHOUT Afib requires more data from forthcoming randomized clinical trials?
  20. Select one*  


    Invalid Input Please Select one

  21. Although optional, we respectfully request that you complete the activity evaluation form, since your feedback assists in the development of future educational activities.

  22. Background

    Please rate each question using a scale of 1 to 5 (1 = Beginner, 5 = Advanced)


  23. I would consider my level of expertise in the subject matter prior to the webcast as:
    Invalid Input Please Select one

  24. I would consider my level of expertise in the subject matter after the activity
    Invalid Input

  25. Considering my experience and background, the material presented was:
    Invalid Input Please Select one

  26. Extent to which activity met the identified objectives
    Please rate each question using a scale of 1 to 5 (1 = Not Met, 5 = Completely Met)

  27. Review the results of LAAOS III, and assess impact to the practice of surgical LAA exclusion.
    Invalid Input Please Select one

  28. Examine CHA2DS2-VASc Score and Anticoagulation following the Cox Maze Procedure, and alternative scoring system options.
    Invalid Input Please Select one

  29. Assess the rationale and benefits of standalone epicardial LAA exclusion for thromboembolism prevention in Atrial Fibrillation.
    Invalid Input Please Select one

  30. Review the rationale and benefits of prophylactic epicardial LAA exclusion for thromboembolism prevention in high-risk patients
    Invalid Input

  31. Information Presented
    Please evaluate the information that was presented by answering Yes, No, Maybe or Not Applicable

  32. Reinforced my current practice/treatment habits:
    Invalid Input Please Select one

  33. Will improve my practice/patient outcomes:
    Invalid Input Please Select one

  34. Enhanced my current knowledge base:
    Invalid Input Please Select one

  35. Provided new ideas or information that I expect to use:
    Invalid Input Please Select one

  36. Information gained from this conference will result in making a change in your practice:
    Invalid Input Please Select one

  37. Future activities on this subject matter is important to my practice:
    Invalid Input Please Select one

  38. Addressed a professional practice gap:
    Invalid Input Please Select one

  39. Was free of commercial bias/influence:
    Invalid Input Please Select one

  40. What barriers do you anticipate in incorporating best practices learned in this activity into clinical activities or quality improvement initiatives at your institution?
    Invalid Input

  41. What mechanisms can you identify to overcome these barriers?
    Invalid Input

  42. (*) Required Fields
  43. Invalid Input

Editorial Board | Author Guidelines | About Us | Contact Us | Submit Manuscript | Subscribe | Terms of Use | Privacy Policy

505 South Lenola Road, Suite 121, Moorestown, NJ 08057

  Copyright © 2011-2024  MediaSphere Medical LLC.  All Rights Reserved.   

Website Design Internet Marketing by DigitalSequence